Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116245 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Meenu Kaushal Sharma und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Mycobacterium tuberculosis, Antitubercular Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Agency of Canada, Public Health Agency of Canada—Genomic Research Development Initiative 7.
Abstract (Originalsprache)
Phenotypic susceptibility testing of the Mycobacterium tuberculosis complex (MTBC) isolate requires culture growth, which can delay rapid detection of resistant cases. Whole genome sequencing (WGS) and data analysis pipelines can assist in predicting resistance to antimicrobials used in the treatment of tuberculosis (TB). This study compared phenotypic susceptibility testing results and WGS-based predictions of antimicrobial resistance (AMR) to four first-line antimicrobials—isoniazid, rifampin, ethambutol, and pyrazinamide—for MTBC isolates tested between the years 2018–2022. For this 5-year retrospective analysis, the WGS sensitivity for predicting resistance for isoniazid, rifampin, ethambutol, and pyrazinamide using Mykrobe was 86.7%, 100.0%, 100.0%, and 47.8%, respectively, and the specificity was 99.4%, 99.5%, 98.7%, and 99.9%, respectively. The predictive values improved slightly using Mykrobe corrections applied using TB Profiler, i.e., the WGS sensitivity for isoniazid, rifampin, ethambutol, and pyrazinamide was 92.31%, 100%, 100%, and 57.78%, respectively, and the specificity was 99.63%. 99.45%, 98.93%, and 99.93%, respectively. The utilization of WGS-based testing addresses concerns regarding test turnaround time and enables analysis for MTBC member identification, antimicrobial resistance prediction, detection of mixed cultures, and strain genotyping, all through a single laboratory test. WGS enables rapid resistance detection compared to traditional phenotypic susceptibility testing methods using the WHO TB mutation catalog, providing an insight into lesser-known mutations, which should be added to prediction databases as high-confidence mutations are recognized. The WGS-based methods can support TB elimination efforts in Canada and globally by ensuring the early start of appropriate treatment, rapidly limiting the spread of TB outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
- Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- Laboratoire de Santé Publique du Québec-Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC H9X 3R5, Canada.
- Diagnostic Services, Shared Health, Winnipeg, MB R3C 3H8, Canada.
- Regina Qu'Appelle Health Region, Regina, SK S4T 1A5, Canada.
- Public Health Laboratory, B.C. Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.
ORCID-Profile: Meenu Kaushal Sharma, Michael Stobart, Heather Adam, Hafid Soualhine
Förderung
- Public Health Agency of Canada
- Public Health Agency of Canada—Genomic Research Development Initiative 7
Zitieren
APA
Sharma, M. K., Stobart, M., Akochy, P. M., Adam, H., Janella, D., Rabb, M., Alawa, M., Sekirov, I., Tyrrell, G. J., & Soualhine, H. (2024). Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116245
Vancouver
Sharma MK, Stobart M, Akochy PM, Adam H, Janella D, Rabb M, et al. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116245
BibTeX
@article{Sharma2024,
author = {Sharma, Meenu Kaushal and Stobart, Michael and Akochy, Pierre-Marie and Adam, Heather and Janella, Debra and Rabb, Melissa and Alawa, Mohey and Sekirov, Inna and Tyrrell, Gregory J and Soualhine, Hafid},
title = {Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116245}
}
EUVIMED